News and Events

New pilot trials spark community interest

It’s no secret that many people living with HIV (PLWH) both use and claim therapeutic...

In Memory of Dr. Mark Wainberg

  The staff and management of the CTN extend our heartfelt condolences on the sudden...

Postdoc Spotlight: Dr. Malika Sharma

HIV rates in Canada continue to rise despite new tools at our disposal to prevent...

New Study — CTN 302: Visioning Health II

Enhancing HIV-Positive Aboriginal Women’s health through culturally-grounded and arts-informed research Health is more than just...

Five HIV-related Myths Debunked

So what about the gut?

The advent of combination antiretroviral therapy (cART) has greatly changed the way people live with...

Study demonstrates the acceptability of HIV point-of-care testing in inner-city emergency department

A collaborative group of scientists in Vancouver have published results from a study showing the...

HPV vaccine safe for HIV+ girls and women: CTN 236

The safety and potential efficacy of vaccination against the human papillomavirus (HPV) in HIV-positive women...

Turning to PrEP for Prevention

February saw a possible turning point in the prevention of HIV, when Health Canada approved Truvada...

Postdoc Spotlight: Dr. Nathan Lachowsky

“Young guys today didn’t live through the AIDS crisis,” says CTN postdoc Nathan Lachowsky in...

Seeking a Reprieve for Heart Disease: CTN Partners with the ACTG

The REPRIEVE trial (A5332, CTN 293 – Randomized Trial to Prevent Vascular Events in HIV)...